Paper500658
Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.
Nelson DJ and 8 others. J Biol Chem, 1979. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation. Papers, record 500658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/500658
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Allopurinol | Major topic |
| Anthelmintics | Major topic |
| Leishmania | Major topic |
| Ribonucleosides | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Kinetics | |
| Phosphorylation |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40628941 | Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis. | Commun Biol | 2025 | https://conductscience.org/library/papers/40628941 | PubMed |
| 37835666 | High Performance Liquid Chromatography Analysis and Description of Purine Content of Diets Suitable for Dogs with Leishmania Infection during Allopurinol Treatment-A Pilot Trial. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/37835666 | PubMed |
| 36355877 | An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics. | Trop Med Infect Dis | 2022 | https://conductscience.org/library/papers/36355877 | PubMed |
| 27606425 | Characterization of a Novel Endoplasmic Reticulum Protein Involved in Tubercidin Resistance in Leishmania major. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/27606425 | PubMed |
| 26334763 | A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26334763 | PubMed |
| 24277328 | Pyrazolopyrimidine metabolism in parasitic protozoa. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277328 | PubMed |
| 24272839 | Inosine analogs as anti-leishmanial agents. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272839 | PubMed |
| 17851411 | Symmetrically and unsymmetrically bridged methylenebis(allopurinols): synthesis of dimeric potential anti-gout drugs. | Molecules | 2007 | https://conductscience.org/library/papers/17851411 | PubMed |
| 16418526 | Drug resistance in leishmaniasis. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418526 | PubMed |
| 16127040 | Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16127040 | PubMed |
| 8517715 | Effects of probenecid on the pharmacokinetics of allopurinol riboside. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8517715 | PubMed |
| 8335625 | Purine metabolism by intracellular Chlamydia psittaci. | J Bacteriol | 1993 | https://conductscience.org/library/papers/8335625 | PubMed |
| 8335624 | Pyrimidine metabolism by intracellular Chlamydia psittaci. | J Bacteriol | 1993 | https://conductscience.org/library/papers/8335624 | PubMed |
| 7479655 | 3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo. | Parasitol Res | 1995 | https://conductscience.org/library/papers/7479655 | PubMed |
| 6982678 | Comparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6982678 | PubMed |
| 6835838 | A convenient synthesis of 6-amino-1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidin-4-one and related 4,6-disubstituted pyrazolopyrimidine nucleosides. | Nucleic Acids Res | 1983 | https://conductscience.org/library/papers/6835838 | PubMed |
| 6817705 | Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6817705 | PubMed |
| 6712205 | Biological action of inosine analogs in Leishmania and Trypanosoma spp. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6712205 | PubMed |
| 6605408 | Purine salvage networks in Giardia lamblia. | J Exp Med | 1983 | https://conductscience.org/library/papers/6605408 | PubMed |
| 6573672 | Pyrimidine metabolism in Tritrichomonas foetus. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6573672 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/500658
GET https://conductscience.org/api/papers/v1/500658/cited_by?page=2